Microbiological Diagnosis
Due to the 100% fatality rate of the infection, laboratory confirmation is most often performed post-mortem. Main methods:
- Microscopic Examination. Smear imprints or tissue sections of the hippocampus, cerebellum (Purkinje cells), and cerebral cortex are examined for specific cytoplasmic inclusions—Negri bodies. Stains such as Romanowsky-Giemsa, Turevich, Mann, or Muromtsev are utilized.
- Rapid Diagnostics. Allows for the swift detection of viral antigens in brain tissue or submandibular salivary glands using the direct fluorescent antibody (DFA) test.
- Biological Assay. Involves intracerebral inoculation of suckling mice. Animals are monitored for up to 28 days, though death typically occurs within a week. For subsequent agent identification, ELISA or neutralization tests using rabies immunoglobulin are applied.
In rare instances, antemortem diagnosis is attempted in patients. Specimens include skin biopsies or corneal imprints (analyzed via DFA). Viral isolation from cerebrospinal fluid, tears, or saliva via mouse inoculation, as well as antibody detection via complement fixation and ELISA, are also possible.
Emergency Prophylaxis and First Aid
No specific treatment exists for clinical rabies—only supportive care is available. Timely prophylaxis is the only intervention capable of saving an infected individual. Success relies on active post-vaccination immunity developing prior to the end of the incubation period.
Wound Management Protocol:
- Immediate and thorough flushing of the wound with soapy water.
- Antiseptic treatment of the wound edges with alcohol or iodine solutions.
- Surgical debridement of wound margins.
- Crucial rule: do not suture the wound for the first 3 days.
The biting animal (if known) must be placed under mandatory veterinary observation for 10 days to rule out or confirm rabies.
Vaccination (Specific Prophylaxis)
Specific immunoprophylaxis is divided into pre-exposure prophylaxis (indicated for veterinarians and animal handlers) and post-exposure prophylaxis (administered after a potential exposure).
- Vaccines. Modern regimens utilize cell-culture inactivated vaccines (inactivated via UV or gamma irradiation). Recombinant vaccines containing glycoprotein G are also under development. Vaccination stimulates cellular immunity, antibody production, and interferon synthesis.
- Passive Immunization. Severe exposures or multiple bites require immediate protection. In such cases, rabies immunoglobulin is administered to establish passive immunity, safeguarding the patient until active post-vaccination antibodies are produced.
Historically, the first rabies vaccine was developed by Louis Pasteur in 1885. He derived the so-called "fixed" virus through 133 consecutive passages of "street" virus through rabbit brains. The pathogen lost its virulence for humans, and its incubation period shortened to 7 days. Attenuation was achieved by drying the spinal cords of infected rabbits over potassium hydroxide.